Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
13.01
-0.02 (-0.15%)
Oct 5, 2026, 9:30 AM EDT - Market open
ARCT Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -93.28 | -65.78 | -80.94 | -29.73 | 9.35 | -203.67 |
Depreciation & Amortization | 2.75 | 3.03 | 3.54 | 2.96 | 1.53 | 1.19 |
Loss (Gain) From Sale of Assets | 0.02 | - | - | - | - | - |
Asset Writedown & Restructuring Costs | 1.9 | 1.9 | - | - | - | 5 |
Loss (Gain) on Equity Investments | - | - | - | - | 0.52 | -0.52 |
Stock-Based Compensation | 21.1 | 25.41 | 37.99 | 34.65 | 30.61 | 28.92 |
Other Operating Activities | 0.24 | 0.38 | 0.47 | -33.36 | 2.55 | 1.41 |
Change in Accounts Receivable | 15.39 | -1.59 | 28.09 | -29.3 | 0.6 | -1.24 |
Change in Accounts Payable | -6.21 | -2.96 | 1.92 | -2.24 | -3.11 | -0.77 |
Change in Unearned Revenue | -13.76 | -23.87 | -55.21 | 38.61 | -14.69 | 32.79 |
Change in Other Net Operating Assets | -0.89 | -10.78 | 4.39 | 0.31 | 4.65 | 1.84 |
Operating Cash Flow | -72.73 | -74.27 | -59.75 | -18.1 | 31.99 | -135.04 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.09 | -0.23 | -0.65 | -2.9 | -7.73 | -3.41 |
Sale of Property, Plant & Equipment | 0.05 | - | - | - | - | - |
Investing Cash Flow | -0.04 | -0.23 | -0.65 | -2.9 | -7.73 | -3.41 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 15 | - | 20 | - | 46.6 |
Long-Term Debt Repaid | - | -15 | - | -47.36 | -5 | - |
Net Debt Issued (Repaid) | - | - | - | -27.36 | -5 | 46.6 |
Issuance of Common Stock | 12.93 | 13.38 | 5.42 | 3.28 | 2.14 | 1.42 |
Financing Cash Flow | 12.93 | 13.38 | 5.42 | -24.09 | -2.86 | 48.02 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -59.84 | -61.12 | -54.98 | -45.09 | 21.41 | -90.43 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -72.82 | -74.5 | -60.4 | -21 | 24.27 | -138.45 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -247.96% | -90.82% | -39.65% | -12.59% | 11.78% | -1120.23% |
Free Cash Flow Per Share | -2.60 | -2.72 | -2.24 | -0.79 | 0.90 | -5.26 |
Levered Free Cash Flow | 19.26 | 9.18 | -9.02 | -82.07 | 15.96 | -74.77 |
Unlevered Free Cash Flow | 19.26 | 9.18 | -9.02 | -82.07 | 15.96 | -74.77 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | - | - | - | 2.13 | 0.81 | 0.68 |
Cash Income Tax Paid | - | - | 1.41 | - | - | - |
Change in Working Capital | -5.46 | -39.2 | -20.81 | 7.38 | -12.56 | 32.63 |